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Rorrrrdam. The Nerhehrds and Hn~mwr. Cmsrrz~ 
06jectives. This study represents tie first pmapeettve. quanti- 
tative mvalysts of the assoctation of progression of coro~~sry 
atheroxlerosis with anatomic site and diameter. 
Bac&mmd. The pmgwsstve wnx efenrenary artery disease 
has been dacumented in maw nn&ere~Mc follow-u0 triats. 
M&ads. The data of348 t&ie&‘wi<h rowuwy a& disrasr 
from the lnternatiooal Nifedilrine Trial on Antiatkerwclerotic 
Tlterapy (INTACT) were rwie&d. Standardized coronary angio. 
grams were taken 3 years apart and were analyzed qumttitattvely. 
The comoary tree was subdivided into 25 segmeots. Tine prog~~ 
siw ei 1,063 pm*rai& coronary stem and the appearance ol
247 t~wly formed stencws (1~s - in relation to the mean 
dtameter d segmea(s t<Z mm, 2 to 3 mm, >3 mm) and to their 
txwhion in Ihc coronary tree tpmrimal, mid, dis’pl) and in the 
tluw major coronary artrrtes. 
Resrh Dewme io the mbdmal diameter of prwirting 
stenoses were largest ia segments that were >3 nun in dinmeter 
m%i” 2 SD 0.23 L 0.5 mm vs. 0.10 * 0.4 mm and 0.02 * 
0.3 mm. 1) < 0.001). in a oroximal oosittoo to.14 * 0.5 mm YS. 
0.09 f o:r ma ando. i 0.3mm;p = o.ass in the rtghl 
romnary artery to.14 t 0.4 otm ys 0.M * 0.4 and 0.w f 
03 nun, p < 0.01). Changes L? percent diuneter ~fezmsB 
of preexisting ~tenase nm lorvert in segnw& that were CZ mm 
in diameter and in a &s&al p&sit& tp = NS). The number ol new 
stenmes&ment was towest in segments that were <2 mm in 
diameter (44 of 1.7% vs. 139 of 1,%7 64 of 1,125, p < O.twl) 
andinadistalpasitiont77d2,310vs.86of1.193md8661.285. 
p < 0.001) aid was t@est tn se~menta ei the iigkt a-awry 
artory (to0 of 1.544 VS. 66 of 1,494 and 72 ci 1,492. P = 0.054). 
(I Aa Cidf Car&l 1993;21:1339-46) 
The progressive course of coronary artery disease has bees 
documented in numerous coronary angiographic follow-up 
trials (I-15). The rate of progression correlated with time 
and presence of risk factors and was found to be higher in 
retrospective (l-5) than in prospective (6-W studies. lden- 
tification of coronary artery sites susceptible to accelerated 
progression of atherosclerosis might provide additional in- 
formation when revascularization procedures in patients 
with multiple lesions are planned. In several retrospective 
studies that used visual film analysis (l-5,16), the proximal 
coronary segments were identified as the sites at which 
atherosclerosis develops and progresses preferentially. 
However. because the angiogrophic measurements in these 
studier were obtained by visual estimation. segments posi- 
tioned peripherally in the coronary tree and those with a 
relatively small diameter may have been neglected. Low 
grade stenoses may be more difficult to identify visually in 
small segments than in large segments and, visual analysis of 
coronary angiogmms is, in geneml. hampered by pvor 
reproducibility of results (17-19). An additional shortcoming 
of these retrospective studies is that most patientc under- 
went repeat angiography far clinical symptoms that ari 
much more likely due to progression of disease in proximal 
than in distal parts of the coronary tree (l-5). The influence 
of the diameter of coronary arteries on the progression of 
atherosclerosis has not been investigated. 
In the present analysis, the results of a prospective study 
using a quantitative film evaluation technique were re- 
viewed. The lntemational Niiedipine Trial on Antiathero- 
sclerotic Therapy (INTACT) wei a prospective, placebo 
controlled. nndomized. double-blind study investigating the 
influence of the calcium channel blocking agent nifedipine on 
rhe progression of coronary artery disease as derived from 
coronary angiogmms (13.20). Because all coronary segments 
with a diameter tl mm were measured in INTACT, WC were 
able to evaluate the progression of coronary disease quanti- 
tatively in relation to segment diameter and thei: position in 
the coronary tree (proximal, mid or distal). Disease progres- 
sion was also compared among the left anterior dcsccoding, 
left circumflex and right coronary arteries. 
Methods 
Study patients. The present analysis was based on the 
changes measured in coronary angiograms perfomed 3 
vears aoart in 348 oatients included in INTACT. Inclusion 
&iteria’of this study comprised the presence of moderately 
advanced coronary atherosclerosis, that is, one or a few 
coronary st~uoscs. Exclusion criteria incl;idcd :hc presence 
of diffuse coronary disease and complete occlusion of more 
than one major epicardial coronary artery (13,201. Before 
and after au average treatment period of 1,094 _C147 days, 
standardized coronary angiograms were performed in 175 
patients who received placebo and 173 who received nifed- 
ipine (312 men ad 36 women, average age 53 f 6 years). Of 
the 425 patients initially included in INTACT, follow up 
angiograms were not obtained in 77 because of clinical 
events (n = 21) or patient refusal (n = 56). 
During the 3-year period of treatment after the initial 
angiogmm. 124 clinical events occurred in 80 patients: 57 
events in 31 patients receiving placebo and 67 events in 49 
patients receiving nifedipine (p = 0.51). Concomitant drug 
therapy was permitted and included nitrates (43% of pa- 
tients), beta-adrenereic blocking aaents (38%). asnirin _ _ 
(33%), anticoagulant Gents (15%) and lipid-lowering drugs 
(9%). In this study none of the concomitantly administered 
drugs had an influence on the progression of coronary artery 
disease. 
nary segments, angiographic projections and tine frames 
adequate for quamkaGve analysis were selected by an exp-a- 
rienced cardiologist. Measurements of coronary morphology 
were performed with the computer-assisted contour detef- 
tion system (Coronary Angiography Analysis System 
[CAASI). which has been described previously (23-25). 
Frame sections of interest were rnxgnitied twofold and were 
convened into video format. These imaaes were diaitized in 
a matrix of SIZ x 512 pixels, the calibiated size if a pixel 
representing =O.l mm’ in the patient. These data were 
transferred to a PDP I1144 or PDP I1124 computer for 
storage and further calculations. 
Clinical and angiographic baseline data were not different 
between patients receiving placebo or nifedipine therapy 
(Table 1). About one third of patients had previously un- 
dergone percutaneous coronary angioplasty. In these pa- 
tients, no evidence of restenosis was found on ihe control 
coronary angiogram obtained a3 months after angioplasty. 
Six patients had undergone coronary bypass grafting of 
a single coronary anery before inclusion in the study. 
The coronary arteries supplied by bypass grafts and the 
coronary segments in which angioplasty bad been performed 
were excluded from analysis. A total of 1,105 coronary 
stenoses and I50 coronary occlusions were detected in the 
inclusion angiograms; of these, 449 stenoses and 66 occlu- 
sions were located in the right coronary artery, 317 stenoses 
and 42 occlusions in the left circumflex coronary anery, 324 
stenoses and 42 occlusions in the left anbxior descending 
coronary artery and I5 stenoses in the left main coronary 
artery 
The edge detection algorithm of CAAS has already been 
described in detail (23-25). The cinc frames were calibmted 
by analyzing the diameier of the lip or shaft of the coronary 
catheters (size SF) and comparing the results with the actual 
catheter dimensions that had been measured with a caliper 
immediately after angiography. At the beginning of a seg- 
ment analysis, the operator established a centerline in the 
segment. The upper and lower segment contows were 
derived from the brightness profile achieved perpendicular 
to this centerline. Finally, a diameter function curve was 
An&graphic analysis. Coronary angiograms were taken calculated with the segment’s centerline as the abscissa. A 
in multiple angiographic projections that were identical in mean segment diameter was interpolated by averagingdiam- 
both angiographic procedures. To achieve maximal coronary eter measurements from distances of 0.1 mm along the 
vasodilation, IO mg of isosorbide dinitrate was administered centerline. In the presence of a stenosis. an additional 
sublingually IO min before angiography (X22). Cine films algorilhro was applied constructing a reference diameter 
were analyzed in Hannover and Rotterdam with identical Function that repxsented the best approximation of the 
methods. and a comparable number of coronary lesions was original segment contours at the site of the stenosis on the 
measured in the two centers (Mantel-Haenszel test). Caro- basis of adjacerd normal subsegments (24). From the mini- 
mal slenosis diameter and the reference diameter at the we 
of stenosis, the percent diometer stenosis was calculated. 
Finally. the pincushion distorrion of the segment contours 
was corrected by applying a specml algorithm that was based 
on standardized grid films of all image nmplitiers involved in 
the study (2X26). 
A coronary stenosis was defined as a localized r2OF 
reduction in coronary diameter. This definition was based on 
the standard deviation (SD) of the mean differences between 
measurements of the percent degree of stenoses in standard- 
ized an&&rams repeated within I h. This high threshold 
(about three times the SD) was chosen to exclude stenosis 
artifacts (25). F’rogressian of coronary disease was defined as 
follows: I) Progression of preexisting stenoses was catcu- 
lated by averaging the changes in minimal stenosis diameter 
and in percent diameter stenosis over all stenoses and, to 
define progression as a categoric value. by arbitrarily select- 
ing a threshold increase of rZO% in percent diameter steno- 
sis to identify individual settose~ with progression. 2) Pro- 
gression of corottar~ onery disease was also defined by 
the appearance of new lesi&s (stenoses and occlusions) in 
the follow-up angiogiiams at arterial sites free of stenoses 
in the inclusioo angiogrxns. For separate investigation of the 
low incidence of stenosis regression with regard to diameter 
and location of segments. a threshold change had to be 
chosen. We arbitrarily defined a n20% decrease in degree of 
stenosis as regression. 
According to the INTACT protocol, all epicardial coro- 
ttwy segments with B mean diameter ~1.0 mm were ana- 
lyzed, ii possible, even if they were located in distal parts 
of the coronary tree. The individual segments defined in 
INTACT are presented in Figure I. The definition of I5 
segments ws based on the recommendations of the Amer- 
ican Heart Association (27). In addition. 10 side branches 
were defined. An average of 13 + 3 (range 5 to 20) segments/ 
patient were analyzed. 
The segments were categorized according to size (mean 
diameter ~2 mm. 2 to 3 mm or 23 mm), position in the 
coronary tree Iproximal. mid or distal) and location is the 
three major coronary arteries (letI anterior descending. IeR 
circumRex or right coronary artery, excluding the left main 
troak). The left main trunk,& well as the pro&al segments 
of the three m$or coronary arteries. were considered to be 
in the proalmal position. The first obtuse marginal branch 
tposterolatenl la) and the midsegments of the three COT+ 
nary arteries were defined to be in the midposition and the 
remaining ssgments in the distal position (Fig. I). Tbe 
position of a stenosis in proximal. odd or distal pats of a 
segment was not considered in this analysis. 
Statistics. Different two-sided statistical tests were ap 
plied to compare the two treatmentgroups. The Cwhran test 
for linear trend was used for quantitative variables tith only 
a small number of categories; for all other quantitative 
variables a modified, test with separate variance estimation 
was used. Diffemtces between categoric w&&s were 
tested bv the chi-square test or Fisher exact test. deoendine . _ 
on the number of cells and the cell contents. For segment- or 
stenosis-related analysis in which the subjects were not 
statistically independent. the mixed model analysis of vati- 
once ,was used (28). In this analysis the patient was treated as 
a random effect. treatment and segment location and diam- 
eter as fixed effects and the segment or stenosis parameters 
as dependent variables. All given p values were two toiled 
and were regarded as significant only when < 0.05. 
Baseline data. A summary of the frequency of analysis of 
the 25 defined segments is provided in Table 2. Not surwis- 
isgly. proximal Segments u&e analyzed most frequentl$. In 
total. 4.848 segments were analyzed in both angiograms; 
mean segment diameter ranged from 1.0 mm to 6.2 mm 
Tabk 2. Frequency of Segment Analysis, Number of Preexisring 
Stenoses and Number of New Lesions Related to the Individual 
Camnary Seamems 
Segment niamrter 
(mm) p “all e __- 
Sesment pasilion 
Proximal 9.3 f 0.8 
Mid Z.4 t 0.6 ~OWI 
Dirtnl 2.0 + 06 
camnary Yeslet 
RCA 2.6 I: 0.8 
L.0 2.2 + Q 7 i Q.W, 
LCX 2.2 t 0.7 - 
Abbrevidians ils tn Table 2. 
Abbreviations as in Table 1 
I) zed on both occasions was 39 f I I% (range 20% to 78%) 
in the inclusion angiograms, the majority of stenoses 
( ,023 = %%) having <60% obstroctioo. Forty-two ddi- 
tional stenoses analyzed in the inclusion angiwms could 
not be reanalyzed at follow-up stttoy because of pear tilm 
quality or occlusion ofmore proximal segments. The number 
of preexisting stenoses analyzed in the 25 segments is listed 
‘n Table 2. The number and details of the existing stenoses 
classified according to diameter and location of diseased 
segments are shown in Table 4. 
Changea belween pogioguns. Because nifedipioe was 
demonstrated to exert no influence on the changes in preex- 
isting stenoses (13), these data are sot presented separately 
for the treatment groups. The changes in minimal diameter 
and percent diameter stenosis of existing stenoses were 
averaged after categorizing the diseased segmems according 
to diameter and location (Fig. 2 to 4). Changes in minimal 
stenosis diameter were most extreme in segments ~3 mm in 
diameter (p < 0.001). in proximal segments (p = 0.081) and 
in the right coronary artery (p < 0.01). However, these 
differences within the location categories were mainly due to 
the differences in segment diameter: the relation between 
segment location and change in stenosis diameter was no 
longer significant when correction was made for segment 
diameter (Fig. 3 and 4). Changes in percent diameter stenosis 
of preexisting stenosea were lowest in segments with a 
diameter C2 mm and in a distal position (p = NS, Fig. ? to 
4). Progression of individual existing stenoses, defmed as a 
~20% increase in percent diameter stenosis, is presented in 
Table 5. There was a slight trend toward more progression in 
segments >3 mm in diameter than in smaller segments (p = 
NS). The incidence of regression, defined as a a?O% de- 
crease in diameter stenosis, is demunsrrated in Table 5: the 
rate of regression did not differ among Ihe segment cafego- 
d-s analyzed. 
A total of 241 new coronary lesions (228 stenws, 19 
occlusions; average percent diameter stenosis 39 c I%, 
range 20% to 82%) were detecled in the follow-up angio- 
grams. The number of new coronary lesions/segment was 
significantly lower in patients receiving mfedipine therapy 
(O.lM3 f 0.21) than in those receiving placebo (0.059 t 0.24; 
Figure 3. Changes (h) in preexisting stenoses in r&lion to (he 
p&ion of coronary segmene in the coronary tree. The p vdus in 
parwGxw refer to the analysis using the scgmenr diameter as 
covaiiate. 
p = 0.039). The number of *ew lesions measured in the 25 
coronary segments is listed in Table ?; it was highest in the 
proximal and rmd right coronary artery and in the proximal 
left circumflex coronary artery. When new lesions were 
categorized according to diameter and location of diseased 
segments. they were found least frequently in segments with 
a diameter c? mm (p < 0.001) and in distal segments Up c 
0.001. Table 6). However. the absolute number of new 
lesions was comparable in the proximal, mid and distal 
Table 5. Number of Coronary Stenores With Progression or 
Regression of Drerse in RelaliMl to Segment Diameter and 
Position and Coranarv Vessel 
Table 6. Number ol New Lesions Cowpared li!h the Ntm~ber of 
Coronary Segments in Relation to Segment Diame:cr and Position 
and Coronary Vessel 
Segment diameter 
>3 mm 33,561 6%) WSM (5%) I 
segment categories. Only 25 (32%) of 71 new lesions in the 
distal position were found in segments with a diamete: 
<2 mm. In the right coronary artery, significantly more new 
lesionsisegmenl developed than in the other coronary arter- 
ies (p = 0.044). However, this difference was no longer 
significant, when segmem diameter was used as covariate 
(p = 0.40, Table 6). 
Discussion 
In the present reanalysis of a prospective angiographic 
study, we quantitatively assessed the pmgression of coro- 
nary athemsclerosis in relation to the diameter and location 
of the segments. Progression of disease was observed pre. 
dominantly in segments with a mean diameter >2 mm and in 
those located in proximal or midparts of the coronary tree. 
Among the three coronary arteries, progression occurred 
most frequently in the right coronary artery. 
!n a retrospective study using visual film analysis, 
Bruschke and coworkers (4) analyzed dilTerences in the 
progression of coronary artery disease in relation to the 
location of segments. In agreement with our study, overall 
progression prevailed in the right coronary artery segments 
and the midsegment of the left anterior descending coronary 
artery in their analysis. Proximal and midsegments of the left 
circumflex coronary artery were also more likely to manifest 
progression of disease than were distal segmects. In three 
additional refrospective trials with visual film inspection. 
progression of disease was found to occur predominantly in 
the right coronary artery (1.3,5). In the identical studies, the 
greatest disease progression at follow-up was observed in 
proximal segments. However, this finding could be easily 
explained by the fact that retrospective analyses describe a 
highly selected group of patients submitted to follow-up 
angiograpkv for clinical symptoms. Progression of coronary 
disease in $raimal segments would he more likely to cause 
clinical symptoms than would progression in distal seg- 
ments. Because the angiographic data in these studies were 
estimated visually, it was not possible to compare progres- 
sion of atherosclerosis with coronary segment diameter. 
Therefore, a prospective study using a quantitative film 
analysis technique was mandatory to verify the results 
obtained in these retrospective trials and to investizate the 
influence of coronary diameter on progression of at&o&- 
K&. 
The clinical relevance of the development of new cow 
nary lesions is well established (2,4,8,14). and the proportion 
of n:wly formed stenosw rapidly progressing to complete 
occlusion has previously been shown to be high (15.16. 
29.30). Angiogmphically documented socalled new lesions 
with obstmction of >20% at follow-up probably represent 
the progression of early atherosclerosis in which plaques 
were too small to be definitely identified in the previous 
angiogram (that is, <20%) (31). In INTACT, nifedipine 
significantly inhibited the progression of these early athem- 
sclerotic olaoues to stenoses >20%: that is. i! inhibited the 
formation of’so-called new lesions. In more advanced SE- 
noses, howeve:, with baseline obstruction >20%, a trend 
toward an inhibitory effect of nifedipine on progression was 
not evident (13). The suppression of progression of early 
atherosclerotic plaques with nifedipine aswciated with the 
failure to influence advanced coronary stenoses is consistent 
with results from a recent study analyzing the influence of 
the dihydropyridine calcium entry blocker nicardipine on the 
progression of coronary artery disease in humans (14). The 
inhibitory effect of nifedipine on the development of new 
coronary lesions proved to be independent of segment 
diameter and location. New lesions were found significantly 
more frequently in the right coronary artery than in other 
coronary arteries; they appeared significantly less frequently 
in segments <2 mm in diameter and in distal parts of the 
coronary system. Distal segments developed significantly 
fewer new lesions even when the segment diameter was 
taken into a.ccount. However, the absolute number of new 
lesions in the category of distal segments was high, particu- 
larly in segments >2 mm in diameter. The greater number of 
new lesions in the right coronary anery was probably due IO 
the size of the segments in this artery, which were, on an 
average. significantly larger than segments of the left corc- 
nary system. 
In the cmrent analysis, changes in the minimal diameter 
of preexisdng stenoses were greatest in segments >3 mm in 
diameter. This is the logical consequence of the fact thm 
such segmems can be affected by greater plaque masses. 
which can show more absolute growth than that ofplaques in 
small segments. Because of differences in segment size, 
diameter changes in preexisting stenoses were mart extreme 
in proximal segments (p = 0.08) and in the right coronary 
artery (p < 0.01). With regard to changes in percem diameter 
stenosis of preexisting stenoses. however. only trends were 
observed toward less progression in small segments and in 
the distal position; no differences were found among the 
three coronary arteries. 
Arterial size seems to be an important variable for both 
the progression of preexisting corona~y srenosrs and the 
development of new coronary lesions. This raises !he ques- 
lion whether methodologic shortcomings might be rcsponsi- 
ble for the differences !I progression among all analyzed 
segment categories. In fact, a methodologic limitation may 
contribute to the leer-r ixidence ofprogression in segment5 
with a diameter <2 mm but cannot be its main reason. In 
quantitative coronae d:lgiclgraphy. arterial diameters 
<I mm are generally overestimated for reasons such 6s 
motion blur. nonorthogonality of :hc X ray beam, inade- 
quate spatial resolution at several points in the imagmg chain 
and focal spot blurring (23.32). Overestimation of stenosis 
diameter in smdl segments may lead to undereslimalion of 
both stenosis degree and stenosis progression in these seg- 
ments. However, if this methodologic limitation were the 
cause for the lesser progression in small coronary arteries. 
the incidence of regression. that is. a decrease in percent 
diameter stenosis, should also be underestimated in small 
segments. However. this was not our observation. Therc- 
fore. factors olher than methodologic shortcomings must 
cause the correlation of atherosclerosis progression with 
coronary artery size. 
The mechanisms by which atherosclerosis leads prefer- 
entially 10 angiographically visible changes in some coronary 
segments while affecting other segments less frequently is 
poorly understood. Law blood low associated with low 
shear stress has been discussed as a factor promoting the 
development of atherosclerosis (33.34). Among Ihe coronary 
arteries, blood Row has been shown to be lowest in the tight 
coronary artery, which might explain the propensity of this 
artery to develop atherosclerotic lesions (34-36). Singb (I61 
identified the three segments ofthe right coronary artery. the 
mid segment of the left anterior descending coronary artery 
and the proGal and mid segments of the IeR circumflex 
coronary artery as sites of extensive movement stress during 
cardiac systole because these points are junctions between 
moving and fixed parts of the arteries. These same segments 
have been demonstrated to be involved in coronary artery 
disease in our study and in other investigations (1.3-S). 
Glagov et al. (34) identified vessel branchings, bifurcatinns 
and bends as preferential sites of atherosclerosis and con- 
cluded that turbutence, reduced wall shear stress and SXCQ- 
sive tensile stress were responsible. Flow separations 
caused by bmnchings and bifurcations may have the stron- 
gest impact on the arterial intima, where flow is highest. that 
is, in the proximal and midportions of the coronary arteries. 
It can only be sFculated why the rate of progression of 
dlamerer <2 mm. One hy~&sis may be derived from the 
formula for wal! shear stress (T,) 
T, = 4 #. 
in which the radius (r) of the artery appears in the denomi- 
nator to the third power (p = blood viscosity; Q = volume 
flow) (34). The arterial media is thicker in relation to the 
lumen in small coronary segments, than in large segments; 
rhis finding might be associated with a higher basal vasomo- 
tar tone resulting in higher shear stress. This situation would 
prevent stasis of atherogenic particles. such as thromb- 
cy~zs. monocyres and lipoproteins (37-39). The high vase- 
motor tone of small epicardial coronary segments may be 
reflected in the variabte response of coronary segments to 
vasodilator stimuli. the extent of vasodilation increasing 
reciprocally to the segment diameters (21,40-42). 
The INTACT study was the first coronary angiogg$hc 
folio%-zp s:& attvmpdng to standardize corooacy vasorno- 
tm tone. Maximal coronary dilation was achieved by admin- 
istration of IO mg of isosorbide d&ate 10 min before 
angiogmphy (21). There standardization efforts arc of par- 
ticular relevance in segments with a small diameter because 
of the intense vasodilation in these segments tier such 
interventions as administration of radiographic contrast me- 
dium or vasoactive drugs (21.40-42). 
Limitations of the study. Because only patients with 
moderate coronary artery disease were included in IN- 
TACT. our results do not allow for acomplete description of 
!he natural evolution ofcoronary artery disease. In addition, 
the course of the disease could not be es&red in patients 
who dropped out because of clinical events or refusal of 
reangiographg (13,20). Therefore, overall progression of 
coronary atherosclerosk may have been underestimated in 
1NTACT. Coronary angioplasty has a substantial influence 
on the evolution of atherosclerosis at the dilation site. 
Therefore. segments previously treated with angioplasty 
were excluded from the analysis. 
Conclusions. In the prospective CvabMion of 348 pa- 
tients with moderate coronary arhemsclerosis, progression 
of the disease was found 10 occur predominantly in coronary 
segments >2 mm in diameter. Associated with their large 
diameter. segments of the right coronary artery exhibited 
more progression than did those of the other coronary 
arteries. Progression was less frequent in segments in the 
distal portion of the coronary tree. than in mid or proximal 
segments. However, a large absolute number of new lesions 
wa!, also found in distal segments, particularly in those 
>2 mm in diameter. These findings indicate the coronary 
artery sites where accelerated progression of atherosclerosis 
can be expected. This knowledge may have an impact on The 
planning of procedures in puients with multipfe coronary 
lesions in whom the extent of revascularization is equivocal. 
disease seems to he particularly tow m segments with a 
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